- Home
- Publications
- Publication Search
- Publication Details
Title
Screening for and Management of Elevated Lp(a)
Authors
Keywords
Elevated lipoprotein(a), Apolipoprotein(a), LDL, Cardiovascular disease, Coronary heart disease, Atherosclerosis, Inflammation, Thrombosis, Fibrinolysis, Oxidized phospholipids, Clinical chemistry, Risk factors, Niacin, Genetics, Mendelian randomization, Screening, Management
Journal
Current Cardiology Reports
Volume 15, Issue 11, Pages -
Publisher
Springer Nature
Online
2013-09-20
DOI
10.1007/s11886-013-0417-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
- (2013) Maya S. Safarova et al. ATHEROSCLEROSIS SUPPLEMENTS
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antisense oligonucleotides for the treatment of dyslipidaemia
- (2012) Maartje E. Visser et al. EUROPEAN HEART JOURNAL
- Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy
- (2012) James M. McKenney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)
- (2012) Taewoo Cho et al. MOLECULAR BIOLOGY OF THE CELL
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteomic Analysis of Aortae from Human Lipoprotein(a) Transgenic Mice Shows an Early Metabolic Response Independent of Atherosclerosis
- (2012) Euan J. Rodger et al. PLoS One
- Lipoprotein(a), Ethnicity, and Cardiovascular Risk
- (2011) Paul M Ridker CIRCULATION
- Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects
- (2011) Salim S. Virani et al. CIRCULATION
- Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
- (2011) Michael H. Davidson et al. Journal of Clinical Lipidology
- Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study
- (2011) Amir Ravandi et al. JOURNAL OF LIPID RESEARCH
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
- (2010) Tracie A. Seimon et al. Cell Metabolism
- European Atherosclerosis Society Screening Recommendations for Lipoprotein(a) and High-Sensitivity C-Reactive Protein: Double Standard or Failure of Evidence-Based Medicine?
- (2010) S. Z. Goldhaber CLINICAL CHEMISTRY
- Lipoprotein(a) and Risk of Type 2 Diabetes
- (2010) S. Mora et al. CLINICAL CHEMISTRY
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Management of Lp(a)
- (2010) W. Virgil Brown et al. Journal of Clinical Lipidology
- Apolipoprotein(a) Isoforms and the Risk of Vascular Disease
- (2010) Sebhat Erqou et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein a: where are we now?
- (2009) Konstantinos Tziomalos et al. CURRENT OPINION IN CARDIOLOGY
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
- (2009) Beate R Jaeger et al. Nature Reviews Cardiology
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) Levels and Risk of Future Coronary Heart DiseaseLarge-Scale Prospective Data
- (2008) Anna Bennet ARCHIVES OF INTERNAL MEDICINE
- Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy
- (2008) Daniel I. Chasman et al. ATHEROSCLEROSIS
- Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin αVβ3
- (2008) Lei Liu et al. BIOCHEMICAL JOURNAL
- A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
- (2008) Claes Bergmark et al. JOURNAL OF LIPID RESEARCH
- Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population
- (2007) Pia R. Kamstrup et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started